AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06118 AUSTAR

Closed 07-15 15:49:49

0.670

-0.020

-2.90%

High0.680	Low0.670	Vol5.00K
Open0.680	D1 Closing0.690	Amplitude1.45%
Mkt Cap343.71M	Tradable Cap343.43M	Total Shares513.00M
T/O3.37K	T/O Rate0.00%	Tradable Shares512.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06118","market":"HK","secType":"STK","nameCN":"AUSTAR","latestPrice":0.67,"timestamp":1784101789180,"preClose":0.69,"halted":0,"volume":5000,"delay":0,"changeRate":-0.02898550724637668,"floatShares":512582000,"shares":513000000,"eps":0.06595,"marketStatus":"Closed","change":-0.02,"latestTime":"07-15 15:49:49","open":0.68,"high":0.68,"low":0.67,"amount":3370,"amplitude":0.014493,"askPrice":0.73,"askSize":4000,"bidPrice":0.67,"bidSize":7000,"shortable":0,"etf":0,"ttmEps":0.07339,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784165400000},"marketStatusCode":5,"adr":0,"listingDate":1415289600000,"exchange":"SEHK","adjPreClose":0.69,"openAndCloseTimeList":[[1784079000000,1784088000000],[1784091600000,1784102400000]],"volumeRatio":0.100806,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06118","defaultTab":"news","newsList":[{"id":"1117977744","title":"AUSTAR maintains 512.58 million issued shares in June 2026; public float requirement met","url":"https://stock-news.laohu8.com/highlight/detail?id=1117977744","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117977744?lang=en_us&edition=fundamental","pubTime":"2026-07-02 14:46","pubTimestamp":1782974812,"startTime":"0","endTime":"0","summary":"Hong Kong–listed AUSTAR Lifesciences Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating stable capital metrics throughout the month. Authorised and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536659","title":"China Harmony Auto Names Leung Oi Kin Independent Non-executive Director as Lau Kwok Fan Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536659","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647536659?lang=en_us&edition=fundamental","pubTime":"2026-06-30 16:42","pubTimestamp":1782808978,"startTime":"0","endTime":"0","summary":"China Harmony Auto names Leung Oi Kin independent non-executive director as Lau Kwok Fan steps downChina Harmony Auto Holding named Leung Oi Kin as independent non-executive director effective June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL9Mzmyj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01051","BK1141","06118","03836","BK1520","BK1239","BK1208"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109555250","title":"AUSTAR Lifesciences Adopts Second Amended & Restated Articles, Enhancing Digital Governance and Capital Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=1109555250","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109555250?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:44","pubTimestamp":1779439452,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (AUSTAR) has approved and adopted a Second Amended and Restated Articles of Association, effective 22 May 2026, following a special resolution passed on the same date. Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637360854","title":"Austar Lifesciences shareholders adopt second amended, restated articles at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2637360854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637360854?lang=en_us&edition=fundamental","pubTime":"2026-05-22 12:29","pubTimestamp":1779424158,"startTime":"0","endTime":"0","summary":"Austar Lifesciences held its annual general meeting on May 22, 2026.Shareholders adopted the audited consolidated financial statements and related directors’ and auditor’s reports for the year ended Dec. 31, 2025.Votes carried resolutions to re-elect the retiring directors.Shareholders renewed general mandates for the board to issue shares, repurchase shares, and extend the issue mandate by shares repurchased.A special resolution adopted a second amended and restated articles of association, replacing the existing articles.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Excha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL7QrylQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104259591","title":"AUSTAR Keeps Issued Shares Steady at 512.58 Million in April; Public Float Requirement Met","url":"https://stock-news.laohu8.com/highlight/detail?id=1104259591","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104259591?lang=en_us&edition=fundamental","pubTime":"2026-05-05 09:42","pubTimestamp":1777945374,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (AUSTAR) reported no changes in either its authorised or issued share capital for the month ended 30 April 2026, according to the company’s monthly return filed with Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174391419","title":"AUSTAR Publishes 2025 ESG Report: Lower Emissions, Higher Renewable Use and Strong Governance","url":"https://stock-news.laohu8.com/highlight/detail?id=1174391419","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174391419?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:46","pubTimestamp":1776944775,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited released its 2025 Environmental, Social and Governance Report, detailing progress in decarbonisation, resource efficiency and stakeholder management across its operations...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193873946","title":"AUSTAR publishes 2025 Annual Report, AGM Circular and ESG Report online; offers shareholders e-communication options","url":"https://stock-news.laohu8.com/highlight/detail?id=1193873946","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193873946?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:43","pubTimestamp":1776944621,"startTime":"0","endTime":"0","summary":"AUSTAR has released its 2025 Annual Report, the circular for the forthcoming annual general meeting dated 24 April 2026, the related proxy form and the 2025 Environmental, Social and Governance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132265884","title":"AUSTAR 2025年营收小幅增长，净利润同比激增142%，业务结构持续优化","url":"https://stock-news.laohu8.com/highlight/detail?id=1132265884","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132265884?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:10","pubTimestamp":1776942606,"startTime":"0","endTime":"0","summary":"AUSTAR Lifesciences Limited在其截至2025年12月31日的年度业绩中，实现营收与盈利的同步改善。报告期内，公司总收入约为人民币15.30672亿元，同比微增2.0%；毛利为人民币2.93271亿元，同比下降2.6%，毛利率由上一年的20.1%略降至19.2%。尽管原材料及运营成本有所上升，公司通过精细化管理及各板块协同，推动综合盈利能力回升。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AUSTAR 2025年营收小幅增长，净利润同比激增142%，业务结构持续优化","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108313020","title":"Austar Lifesciences Schedules 22 May 2026 AGM, Proposes 20% Issuance Mandate and 10% Share Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=1108313020","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108313020?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:04","pubTimestamp":1776942271,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited has issued a notice convening its 2026 Annual General Meeting (AGM) for 10:00 a.m. on Friday, 22 May 2026, at the company’s Shanghai headquarters (Conference Room, Room...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629091838","title":"Austar Lifesciences announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629091838","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629091838?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:02","pubTimestamp":1776942155,"startTime":"0","endTime":"0","summary":"Austar Lifesciences scheduled annual general meeting in Shanghai on May 22, 2026.Shareholders set to vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Meeting agenda includes re-election of directors, including executive directors Ho Kwok Keung, Zhou Ning, Bian Ce, plus non-executive director Ji Lingling.Items also include reappointment of Moore CPA as auditor.Resolutions cover share issuance mandate, share buyback mandate up to 10% of issued shares, plus adoption of second amended and restated articles of association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service ope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL2zzKRs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629838612","title":"Austar Lifesciences publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629838612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629838612?lang=en_us&edition=fundamental","pubTime":"2026-04-23 18:52","pubTimestamp":1776941573,"startTime":"0","endTime":"0","summary":"Austar Lifesciences released annual report for year ended Dec. 31, 2025, showing modest revenue growth alongside a sharp rise in profit.Order intake climbed 11.4% to RMB 1.9 billion, supported by wins in Integrated Process and Packaging Equipment & Systems.Business mix shifted toward equipment and systems, while consulting, digitalization, construction, life science equipment, consumables posted declines.Group stepped up global expansion, adding five new sales agents across US, Greece, Uzbekistan, Egypt, India.Product pipeline broadened with commercial-scale peptide and oligonucleotide production systems, new pre-filled syringe filling machine, dry granulator licensing partnership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL7PY2FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624639396","title":"Shareholders Can Be Confident That Austar Lifesciences' (HKG:6118) Earnings Are High Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=2624639396","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624639396?lang=en_us&edition=fundamental","pubTime":"2026-04-03 06:31","pubTimestamp":1775169095,"startTime":"0","endTime":"0","summary":"When companies post strong earnings, the stock generally performs well, just like Austar Lifesciences Limited's...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/shareholders-can-be-confident-that-austar-lifesciences-hkg61","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6118/austar-lifesciences-shares/news/shareholders-can-be-confident-that-austar-lifesciences-hkg61","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157604518","title":"AUSTAR Posts March 2026 Monthly Return: Share Capital Unchanged, Public Float Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1157604518","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157604518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:44","pubTimestamp":1775015097,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164078913","title":"AUSTAR Life Sciences (06118) Reports 2025 Financial Results: Profit Attributable to Owners Surges 110.24% to RMB33.81 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1164078913","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164078913?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:38","pubTimestamp":1774539498,"startTime":"0","endTime":"0","summary":"AUSTAR Life Sciences (06118) has announced its financial results for 2025. The company reported revenue of approximately RMB1.531 billion, representing a year-on-year increase of about 2%. Profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622886481","title":"BRIEF-Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622886481","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622886481?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:23","pubTimestamp":1774538638,"startTime":"0","endTime":"0","summary":"BRIEF-Austar Lifesciences Posts FY Revenue RMB 1,530.7 MillionMarch 26 (Reuters) - Austar Lifesciences 6118.HK:FY REVENUE RMB 1,530.7 MILLIONPROFIT FOR YEAR ATTRIBUTABLE RMB33.8 MILLIONFurther company coverage: 6118.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX72D084:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139110773","title":"Austar Lifesciences’ 2025 Net Profit Jumps 142.30%, Revenue Reaches RMB 1.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1139110773","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139110773?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:05","pubTimestamp":1774537554,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited reported a strong earnings rebound for the year ended 31 December 2025, with profit more than doubling despite a slight contraction in gross margin. Key Financials (YoY) •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622869146","title":"Austar Lifesciences - Profit for Year Attributable RMB33.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622869146?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:43","pubTimestamp":1774536180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX72D084:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622854280","title":"Austar Lifesciences proposes articles of association amendments; shareholder vote set for May 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854280","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622854280?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:29","pubTimestamp":1774524582,"startTime":"0","endTime":"0","summary":"Austar Lifesciences announced proposed amendments to its articles of association to align with updated Hong Kong Listing Rules requirements.The changes would add provisions to allow the company to hold treasury shares.Shareholders would be able to give instructions and receive corporate action proceeds by electronic means.The amendments would also add provisions for holding and transferring shares in uncertificated form.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL20ZmP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190363908","title":"Austar Lifesciences (06118) Schedules 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1190363908","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190363908?lang=en_us&edition=fundamental","pubTime":"2026-03-16 17:40","pubTimestamp":1773654059,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (Stock Code: 06118) has announced that its board of directors will convene on 26 March 2026. The agenda includes: • Approval of the consolidated results for the financial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144081103","title":"Austar Lifesciences (06118) Announces Monthly Equity Movements for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1144081103","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144081103?lang=en_us&edition=fundamental","pubTime":"2026-03-02 11:41","pubTimestamp":1772422901,"startTime":"0","endTime":"0","summary":"Austar Lifesciences Limited (06118) disclosed its monthly return for equity issuer for the period ended 28 February 2026. The announcement indicates that authorized share capital remained at 10.00...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06118"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.austar.com.hk","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.08},{"period":"3month","weight":-0.1882},{"period":"6month","weight":-0.2959},{"period":"1year","weight":0.0147},{"period":"ytd","weight":-0.2069}],"compareEarnings":[{"period":"1week","weight":0.0359},{"period":"1month","weight":-0.0153},{"period":"3month","weight":-0.0619},{"period":"6month","weight":-0.0959},{"period":"1year","weight":0.0057},{"period":"ytd","weight":-0.0503}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Austar Lifesciences Ltd is a holding company that mainly engaged in providing integrated engineering solutions, and manufacturing and distributing pharmaceutical equipment and consumables. The Company operates six segments: Fluid and Bioprocess Systems segment, Cleanroom and Automation Control and Monitoring Systems segment, Powder and Solid Systems segment, GMP Compliance Services segment, Life Science Consumables segment, and Distribution and Agency of Pharmaceutical Equipment segment. The Company's products include clean utility equipment and systems, bioprocess equipment and systems, powder and solid equipment and systems, pharmaceutical process contamination control products, packaging and closed transport products, biosafety and laboratory animal equipment and consumables, and others.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.045281},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.021974},{"month":3,"riseRate":0.75,"avgChangeRate":0.033505},{"month":4,"riseRate":0.5,"avgChangeRate":0.048541},{"month":5,"riseRate":0.5,"avgChangeRate":0.02789},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.056832},{"month":7,"riseRate":0.5,"avgChangeRate":0.170093},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.055211},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.017498},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.032782},{"month":11,"riseRate":0.545455,"avgChangeRate":0.084856},{"month":12,"riseRate":0.416667,"avgChangeRate":0.024928}],"exchange":"SEHK","name":"AUSTAR","nameEN":"AUSTAR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AUSTAR(06118) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AUSTAR,06118,AUSTAR股票,AUSTAR股票老虎,AUSTAR股票老虎国际,AUSTAR行情,AUSTAR股票行情,AUSTAR股价,AUSTAR股市,AUSTAR股票价格,AUSTAR股票交易,AUSTAR股票购买,AUSTAR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AUSTAR(06118),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AUSTAR(06118) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}